Genomics applied to the treatment of breast cancer
Open Access
- 30 July 2019
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (46), 4786-4801
- https://doi.org/10.18632/oncotarget.27102
Abstract
Breast cancer remains a major health issue in the world with 1.7 million new cases in 2012 worldwide. It is the second cause of death from cancer in western countries. Genomics have started to modify the treatment of breast cancer, and the developments should become more and more significant, especially in the present era of treatment personalization and with the implementation of new technologies. With molecular signatures, genomics enabled a de-escalation of chemotherapy and personalized treatments of localized forms of estrogen-dependent breast cancers. Genomics can also make a real contribution to constitutional genetics, so as to identify mutations in a panel of candidate genes. In this review, we will discuss the contributions of genomics applied to the treatment of breast cancer, whether already validated contributions or possible future applications linked to research data.Keywords
This publication has 88 references indexed in Scilit:
- Improved survival in metastatic breast cancer 1985–2016The Breast, 2017
- Classification, Treatment Strategy, and Associated Drug Resistance in Breast CancerClinical Breast Cancer, 2016
- Cancer statistics, 2015CA: A Cancer Journal for Clinicians, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Targeted therapies for breast cancerJCI Insight, 2011
- Mechanisms of Endocrine Resistance in Breast CancerAnnual Review of Medicine, 2011
- Triple-Negative Breast CancerThe New England Journal of Medicine, 2010
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Molecular portraits of human breast tumoursNature, 2000